lexicon pharmaceuticals inc
(LXRX:Consolidated Issue Listed on NASDAQ Global Select )
Samuel L. Barker Ph.D.
Director, Chairman of Audit Committee and Member of Compensation Committee, Lexicon Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 40 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Dr. Samuel L. Barker, also known as Sam, Ph.D. is a Member of the Strategic Advisory Committee of Symphony Capital LLC. Dr. Barker has been the Chairman of the Board of Lexicon Genetics, Inc. since March 2005 and serves on the Board of Directors of UCB, United States. He has been a Director of Lexicon Genetics Inc. since March 2000. He has been an Independent Director of Cadence Pharmaceuticals, Inc. since 2008. He served at Bristol-Myers Squibb for over 35 years in ...
8800 Technology Forest PlacePhone: 281-863-3000
The Woodlands, Texas 77381
Board Members Memberships*
Member of Board of Trustees
Director, Chairman of Audit Committee and Member of Compensation Committee
Former Director, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
Independent Director and Chairman of Compensation Committee
Henderson State University
University of Arkansas - Fayetteville
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|